Incorporation of fibrin into a collagen-glycosaminoglycan matrix results in a scaffold with improved mechanical properties and enhanced capacity to resist cell-mediated contraction

被引:43
作者
Brougham, Claire M. [1 ,2 ,3 ,4 ]
Levingstone, Tanya J. [1 ,3 ,4 ,5 ]
Jockenhoevel, Stefan [6 ]
Flanagan, Thomas C. [7 ]
O'Brien, Fergal J. [1 ,3 ,4 ,5 ]
机构
[1] Royal Coll Surgeons Ireland, Tissue Engn Res Grp, Dept Anat, Dublin 2, Ireland
[2] Dublin Inst Technol, Sch Mech & Design Engn, Dublin 1, Ireland
[3] RCSI, Adv Mat & Bioengn Res AMBER Ctr, Dublin, Ireland
[4] TCD, Dublin, Ireland
[5] Trinity Coll Dublin, Trinity Ctr Bioengn, Dublin 2, Ireland
[6] Rhein Westfal TH Aachen, AME Helmholtz Inst Biomed Engn, D-52074 Aachen, Germany
[7] Univ Coll Dublin, Sch Med & Med Sci, Dublin 4, Ireland
基金
欧洲研究理事会;
关键词
Fibrin; Tissue engineering; Cardiovascular scaffold; Heart valve; ENGINEERED HEART-VALVES; EXTRACELLULAR-MATRIX; COMPOSITE SCAFFOLD; INTERSTITIAL-CELLS; CROSS-LINKING; STEM-CELLS; PORE-SIZE; TISSUE; STIFFNESS; CULTURE;
D O I
10.1016/j.actbio.2015.08.022
中图分类号
R318 [生物医学工程];
学科分类号
100103 [病原生物学];
摘要
Fibrin has many uses as a tissue engineering scaffold, however many in vivo studies have shown a reduction in function resulting from the susceptibility of fibrin to cell-mediated contraction. The overall aim of the present study was to develop and characterise a reinforced natural scaffold using fibrin, collagen and glycosaminoglycan (FCG), and to examine the cell-mediated contraction of this scaffold in comparison to fibrin gels. Through the use of an injection loading technique, a homogenous FCG scaffold was developed. Mechanical testing showed a sixfold increase in compressive modulus and a thirtyfold increase in tensile modulus of fibrin when reinforced with a collagen-glycosaminoglycan backbone structure. Human vascular smooth muscle cells (vSMCs) were successfully incorporated into the FCG scaffold and demonstrated excellent viability over 7 days, while proliferation of these cells also increased significantly. VSMCs were seeded into both FCG and fibrin-only gels at the same seeding density for 7 days and while FCG scaffolds did not demonstrate a reduction in size, fibrin-only gels contracted to 10% of their original diameter. The FCG scaffold, which is composed of natural biomaterials, shows potential for use in applications where dimensional stability is crucial to the functionality of the tissue. Statement of Significance Fibrin is a versatile scaffold for tissue engineering applications, but its weak mechanical properties leave it susceptible to cell-mediated contraction, meaning the dimensions of the fibrin construct will change over time. We have reinforced fibrin with a collagen glycosaminoglycan matrix and characterised the mechanical properties and bioactivity of the reinforced fibrin (FCG). This is the first scaffold manufactured from all naturally derived materials that resists cell-mediated contraction. In fact, over 7 days, the FCG scaffold fully resisted cell-mediated contraction of vascular smooth muscle cells. This FCG scaffold has many potential applications where natural scaffold materials can encourage regeneration. (C) 2015 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:205 / 214
页数:10
相关论文
共 79 条
[1]
Ahmann KA, 2010, TISSUE ENG PT A, V16, P3261, DOI [10.1089/ten.tea.2009.0708, 10.1089/ten.TEA.2009.0708]
[2]
Fibrin: A versatile scaffold for tissue engineering applications [J].
Ahmed, Tamer A. E. ;
Dare, Emma V. ;
Hincke, Max .
TISSUE ENGINEERING PART B-REVIEWS, 2008, 14 (02) :199-215
[3]
Characterization and inhibition of fibrin hydrogel-degrading enzymes during development of tissue engineering scaffolds [J].
Ahmed, Tamer A. E. ;
Griffith, May ;
Hincke, Max .
TISSUE ENGINEERING, 2007, 13 (07) :1469-1477
[4]
Fibrin-polyethylene oxide interpenetrating polymer networks: New self-supported biomaterials combining the properties of both protein gel and synthetic polymer [J].
Akpalo, E. ;
Bidault, L. ;
Boissiere, M. ;
Vancaeyzeele, C. ;
Fichet, O. ;
Larreta-Garde, V. .
ACTA BIOMATERIALIA, 2011, 7 (06) :2418-2427
[5]
Glycosaminoglycan entrapment by fibrin in engineered heart valve tissues [J].
Alfonso, Abraham R. ;
Rath, Sasmita ;
Rafiee, Parvin ;
Hernandez-Espino, Mario ;
Din, Mahreen ;
George, Florence ;
Ramaswamy, Sharan .
ACTA BIOMATERIALIA, 2013, 9 (09) :8149-8157
[6]
A biodegradable composite scaffold for cell transplantation [J].
Ameer, GA ;
Mahmood, TA ;
Langer, R .
JOURNAL OF ORTHOPAEDIC RESEARCH, 2002, 20 (01) :16-19
[7]
Heart valve development - Endothelial cell signaling and differentiation [J].
Armstrong, EJ ;
Bischoff, J .
CIRCULATION RESEARCH, 2004, 95 (05) :459-470
[8]
ASTM, 2014, D638 ASTM, DOI [DOI 10.1520/E2894-12.2, 10.1520/D0638-14, DOI 10.1520/D0638-14]
[9]
Cross-linking electrospun type II collagen tissue engineering scaffolds with carbodiimide in ethanol [J].
Barnes, Catherine P. ;
Pemble, Charles W. ;
Brand, David D. ;
Simpson, David G. ;
Bowlin, Gary L. .
TISSUE ENGINEERING, 2007, 13 (07) :1593-1605
[10]
Cross-linked type I and type II collagenous matrices for the repair of full-thickness articular cartilage defects - A study in rabbits [J].
Buma, P ;
Pieper, JS ;
van Tienen, T ;
van Susante, JLC ;
van der Kraan, PM ;
Veerkamp, JH ;
van den Berg, WB ;
Veth, RPH ;
van Kuppevelt, TH .
BIOMATERIALS, 2003, 24 (19) :3255-3263